Llwytho...
Agomelatine as monotherapy for major depression: an outpatient, open-label study
BACKGROUND: Agomelatine is a novel antidepressant agonist to MT1 and MT2 subtypes of melatoninergic receptors (MT1 and MT2) and antagonist to 5-HT(2C) subtype of serotonergic (5-HT(2C)) receptors, which has shown antidepressant efficacy in short-term and long-term trials as well as in clinical pract...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2013
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3808155/ https://ncbi.nlm.nih.gov/pubmed/24174876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S49062 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|